These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
102 related articles for article (PubMed ID: 4113201)
41. [Psychotropic drugs in the therapy of hypertension: repercussions in social medicine]. Cittadini A Minerva Med; 1969 Jul; 60(53):2605-7. PubMed ID: 5794589 [No Abstract] [Full Text] [Related]
42. Hypertension, insulin, and alpha 1-blockade. Weidmann P; Ferrari P J Clin Pharmacol; 1993 Sep; 33(9):895-9. PubMed ID: 7901245 [No Abstract] [Full Text] [Related]
43. [Blockade of beta receptors in clinical pharmacology and therapy]. Gersmeyer EF; Spitzbarth H Med Welt; 1967 Apr; 13():764-80. PubMed ID: 5584453 [No Abstract] [Full Text] [Related]
44. Side effects of antihypertensive drugs. Chrysant SG; Frohlich ED Am Fam Physician; 1974 Jan; 9(1):94-101. PubMed ID: 4149117 [No Abstract] [Full Text] [Related]
46. [Clinical study of a new beta adrenergic blockader: Pindolol]. Faivre G; Petitier H; Dodinot B; Hua G Coeur Med Interne; 1972; 11(1):167-74. PubMed ID: 4401293 [No Abstract] [Full Text] [Related]
47. Comparison between alprenolol and chlorthalidone as antihypertensive agents. Bengtsson C Acta Med Scand; 1972 May; 191(5):433-9. PubMed ID: 4555618 [No Abstract] [Full Text] [Related]
48. [Therapeutic experiences with the antihypertensive combination "Briserin"]. Nassehi AT Med Klin; 1970 Oct; 65(43):1884-8. PubMed ID: 4990933 [No Abstract] [Full Text] [Related]
50. [Effect of a beta receptor stimulating drug (Buphenin) on the blood pressure of normotensive and hypertensive pregnant women]. Wolff CH Dtsch Med Wochenschr; 1970 Nov; 95(46):2332-5. PubMed ID: 4394707 [No Abstract] [Full Text] [Related]
51. Alpha 1 antagonistic and antiserotoninergic action during administration of ketanserin. Vermylen J; Fiocchi R; Fagard R; Lijnen P; Staessen J; Amery A Br Med J (Clin Res Ed); 1983 Nov; 287(6404):1551-2. PubMed ID: 6139140 [No Abstract] [Full Text] [Related]
52. [Experiences with a new antihypertensive agent]. Stampfer E Wien Klin Wochenschr; 1971 Jan; 83(4):66-9. PubMed ID: 4994618 [No Abstract] [Full Text] [Related]
53. How should patients treated with alpha-blockers be followed? Insights from an ambulatory blood pressure monitoring database. Ben-Dov IZ; Ben-Arie L; Mekler J; Bursztyn M J Hypertens; 2006 May; 24(5):861-5. PubMed ID: 16612247 [TBL] [Abstract][Full Text] [Related]
54. Attentuation of some effects of anaphylaxis by 1,18-diamino-6,13-diaza-9,10-dithiaoctadecane tetrahydrochloride (WR 149,024). Demaree GE; Frost JS; Heiffer MH; Rothe WE Proc Soc Exp Biol Med; 1971 Apr; 136(4):1332-5. PubMed ID: 4396600 [No Abstract] [Full Text] [Related]
55. [Beta blockers in hypertension treatment Will stepping back come soon?]. Sawicki PT; Anlauf M; Haller H MMW Fortschr Med; 2007 Mar; 149(11):6. PubMed ID: 20104695 [No Abstract] [Full Text] [Related]
56. [Clinical trials with the beta adrenergic blocking agent Visken]. Holló J; Szám I Orv Hetil; 1972 Jun; 113(26):1530-3. PubMed ID: 5038972 [No Abstract] [Full Text] [Related]
58. [Effects of doxazosin and hydralazine on insulin sensitivity and sympathetic function in spontaneously hypertensive rat (SHR)]. Takahashi A; Kushiro T; Kanmatsuse K Nihon Jinzo Gakkai Shi; 1998 May; 40(4):240-4. PubMed ID: 9654906 [TBL] [Abstract][Full Text] [Related]
59. [Essential hypertension: current therapeutic approach]. Manzi M; Santarossa C; Feriozzi S Clin Ter; 1982 Feb; 100(4):337-57. PubMed ID: 6177467 [No Abstract] [Full Text] [Related]
60. Pharmacological basis for combination therapy of hypertension. Dolley CT Annu Rev Pharmacol Toxicol; 1977; 17():311-23. PubMed ID: 17355 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]